These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10820881)

  • 1. [Anti-osteolytic therapy preserves trabecular structure and mechanical properties of bone in tumor osteolysis].
    Kurth AA; Kim SZ; Bauss F; Müller R; Hovy L
    Z Orthop Ihre Grenzgeb; 2000; 138(2):146-51. PubMed ID: 10820881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of an osteolytic tumor on the three-dimensional trabecular bone morphology in an animal model.
    Kurth AA; Müller R
    Skeletal Radiol; 2001 Feb; 30(2):94-8. PubMed ID: 11310206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model.
    Chung YS; Kang HC; Lee T
    Yonsei Med J; 2015 Nov; 56(6):1643-50. PubMed ID: 26446649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB; Evans GP; Hornby SL; Pataki A; Glatt M; Green JR
    Calcif Tissue Int; 2003 Apr; 72(4):519-27. PubMed ID: 12574877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventative ibandronate treatment has the most beneficial effect on the microstructure of bone in experimental tumor osteolysis.
    Kurth AA; Kim SZ; Shea M; Bauss F; Hayes WC; Müller R
    J Bone Miner Metab; 2007; 25(2):86-92. PubMed ID: 17323177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased growth rate and tumor burden of spontaneously metastatic Walker 256 cancer cells in the skeleton of bisphosphonate-treated rats.
    Kostenuik PJ; Orr FW; Suyama K; Singh G
    Cancer Res; 1993 Nov; 53(22):5452-7. PubMed ID: 8221685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The histone deacetylase inhibitor, vorinostat, reduces tumor growth at the metastatic bone site and associated osteolysis, but promotes normal bone loss.
    Pratap J; Akech J; Wixted JJ; Szabo G; Hussain S; McGee-Lawrence ME; Li X; Bedard K; Dhillon RJ; van Wijnen AJ; Stein JL; Stein GS; Westendorf JJ; Lian JB
    Mol Cancer Ther; 2010 Dec; 9(12):3210-20. PubMed ID: 21159607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in bone mass and mechanical properties in a murine model of tumor osteolysis.
    Arrington SA; Schoonmaker JE; Damron TA; Mann KA; Allen MJ
    Bone; 2006 Mar; 38(3):359-67. PubMed ID: 16278105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.
    Kurth AA; Kim SZ; Sedlmeyer I; Bauss F; Shea M
    Bone; 2002 Jan; 30(1):300-6. PubMed ID: 11792601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of bisphosphonates on the mechanical efficiency of normal and osteopenic bones].
    Ferretti JL; Cointry GR; Capozza RF; Mondelo N; Peluffo V; Chiappe A; Meta M; Alippi RM
    Medicina (B Aires); 1997; 57 Suppl 1():83-92. PubMed ID: 9567360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Micro-CT combined with bioluminescence imaging: a dynamic approach to detect early tumor-bone interaction in a tumor osteolysis murine model.
    Fritz V; Louis-Plence P; Apparailly F; Noël D; Voide R; Pillon A; Nicolas JC; Müller R; Jorgensen C
    Bone; 2007 Apr; 40(4):1032-40. PubMed ID: 17251073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic and antiresorptive drugs improve trabecular microarchitecture and reduce fracture risk following radiation therapy.
    Arrington SA; Fisher ER; Willick GE; Mann KA; Allen MJ
    Calcif Tissue Int; 2010 Sep; 87(3):263-72. PubMed ID: 20563797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relations between radiograph texture analysis and microcomputed tomography in two rat models of bone metastases.
    Blouin S; Moreau MF; Baslé MF; Chappard D
    Cells Tissues Organs; 2006; 182(3-4):182-92. PubMed ID: 16914920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent minodronic acid treatment with sufficient bone resorption inhibition prevents reduction in bone mass and strength in ovariectomized rats with established osteopenia comparable with daily treatment.
    Kimoto A; Tanaka M; Nozaki K; Mori M; Fukushima S; Mori H; Shiroya T; Nakamura T
    Bone; 2013 Jul; 55(1):189-97. PubMed ID: 23486179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating the effects of mixed osteolytic/osteoblastic metastasis on vertebral bone quality in a new rat model.
    Wise-Milestone L; Akens MK; Rosol TJ; Hojjat SP; Grynpas MD; Whyne CM
    J Orthop Res; 2012 May; 30(5):817-23. PubMed ID: 22025272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo effects of tetrakisphosphonates on bone resorption, tumor osteolysis, ectopic calcification, and macrophages.
    Van Gelder JM; Breuer E; Schlossman A; Ornoy A; Mönkkönen J; Similä J; Klenner T; Stadler H; Krempien B; Patlas N; Golomb G
    J Pharm Sci; 1997 Mar; 86(3):283-9. PubMed ID: 9050794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of bisphosphonates in the 13762 rat mammary carcinoma model of tumor-induced bone resorption.
    Alvarez E; Westmore M; Galvin RJ; Clapp CL; Considine EL; Smith SJ; Keyes K; Iversen PW; Delafuente DM; Sulaimon S; Zambrano C; Ma L; Sato M; Martin TJ; Teicher BA; Galbreath EJ
    Clin Cancer Res; 2003 Nov; 9(15):5705-13. PubMed ID: 14654555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diphosphonates in the treatment of bone metastases].
    Jung A; Fleisch H
    Schweiz Med Wochenschr; 1981 Dec; 111(49):1878-82. PubMed ID: 6460313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of a rat model for the analysis of densitometric and biomechanical properties of tumor-induced osteolysis.
    Kurth AH; Wang C; Hayes WC; Shea M
    J Orthop Res; 2001 Mar; 19(2):200-5. PubMed ID: 11347691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Inhibitory effect of samarium-153-labeled ethylenediaminetetramethylene phosphonate (EDTMP) on bone invasion and osteolysis in Walker 256 carcinoma bearing rats].
    Shi B; Fu Z; Lei XH
    Zhonghua Zhong Liu Za Zhi; 1997 Nov; 19(6):423-6. PubMed ID: 10920873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.